Skip to content
Stop using now Drug recall · FDA · Published November 8, 2012

Hospira Recalls Carboplatin Injection Due to Crystallization

Hospira Inc. recalls specific lots of Carboplatin Injection vials due to visible particulates (crystals). Check lot numbers Z011711AA and Z011711AB.

🇺🇸 FDA recall #D-154-2013DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 31,326 vials of Carboplatin Injection because visible particles were found during inspection. These particles have been identified as Carboplatin crystals. The recall covers products with expiration date August 2013 distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/48489-hospira-inc-recalls-carboplatin-injection-450-mg-45-ml-10.

Source Summary by GovInfoNow · govinfonow.com/recall/48489-hospira-inc-recalls-carboplatin-injection-450-mg-45-ml-10 · Updated October 13, 2026 · FDA enforcement record: FDA #D-154-2013

Cite this page

“Hospira Recalls Carboplatin Injection Due to Crystallization.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48489-hospira-inc-recalls-carboplatin-injection-450-mg-45-ml-10. Based on FDA recall #D-154-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-154-2013%22&limit=1).

The FDA announced on Nov. 8, 2012, that Hospira Inc. is recalling Carboplatin Injection vials due to crystallization hazards. The agency classified the Class I recall as completed.

How to tell if you have it

  • Brand: Hospira
  • Product: Carboplatin Injection Vials
  • NDC 61703-339-50 (Hospira label)
  • NDC 61703-360-50 (Novaplus label)
  • Lots Z011711AA (Hospira label) and Z011711AB (Novaplus label)
  • Expiration: 08/2013
  • Quantity: 31,326 vials

The hazard

The product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Par Health Recalls Buprenorphine Injections Due to Crystallization (Sept. 8, 2026) and American Regent Papaverine HCl Injection Recall: Particulate Matter Hazard (July 24, 2026).

How to tell if you have this one

Check if you have Carboplatin Injection, 450 mg/45 mL (10 mg/mL) in 45 mL vials. Look for NDC 61703-339-50 (Hospira label) or NDC 61703-360-50 (Novaplus label). Verify the lot number is Z011711AA or Z011711AB and the expiration date is 08/2013.

  • Brand
    Hospira
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Completed
  • Distribution
    Nationwide and Puerto Rico.
Recall numberProduct, codes & lotsQuantityNDC
D-153-2013Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, Hospira, Inc., Lake Forest, IL 60045, Product of Australia, NDC 61703-339-56.; Lot #: Z021650AA, Exp. 08/201323,315 vials61703-339-18, 61703-339-22, 61703-339-50, 61703-339-56
D-154-2013Carboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, NDC 61703-339-50 (Hospira label) and NDC 61703-360-50 (Novaplus label), Hospira, Inc., Lake Forest, IL 60045, Product of Australia.; lots Z011711AA (Hospira label) and Z011711AB (Novaplus label), Exp. 08/201331,326 vials61703-339-18, 61703-339-22, 61703-339-50, 61703-339-56, 61703-360-50
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not administer these vials to patients due to the risk of injecting crystals.

  2. Contact your supplier

    Reach out to the distributor or manufacturer for instructions on returning or disposing of the affected lots.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 3 months after the firm started it.

1. Firm started the recall: Nov 8, 201212. FDA classified it Class I: Feb 6, 201323. Published in FDA’s Enforcement Report: Feb 13, 2013320122013
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-154-2013 (November 8, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-154-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA